Clinical Trials Logo

Acute Stroke clinical trials

View clinical trials related to Acute Stroke.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05524415 Withdrawn - Acute Stroke Clinical Trials

Evaluation of Neurosteer System in Stroke Patients

Start date: January 1, 2023
Phase:
Study type: Observational

This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through a series of EEG recordings during their hospitalization. EEG recordings will be analyzed using proprietary computational analyses.

NCT ID: NCT02907736 Withdrawn - Acute Stroke Clinical Trials

Impact of Neutrophil Extracellular Traps on Tissue Plasminogen Activator Induced Thrombolysis in Acute Ischemic Stroke Patients

THROMBONETS
Start date: November 12, 2015
Phase:
Study type: Observational

Acute Ischemic stroke (AIS) remains a leading cause of adult disability, cognitive impairment and mortality worldwide despite the development of revascularization therapies (intravenous Tissue Plasminogen Activator (t-PA) and endovascular therapy). Thrombosis resistance after IV t-PA therapy is frequent especially in case of AIS with proximal occlusion. In recent years, neutrophil extracellular traps (NETs) have been identified as major triggers and structural factors of various forms of thrombosis. NETs are extracellular webs primarily composed of DNA from neutrophils. A recent study shows that the NETs burden in coronary thrombi is positively correlated with the infarct size and negatively correlated with electrocardiogram (ST-segment) resolution. This later study revealed that in vitro addition of DNase I accelerated the t-PA-induced thrombolysis of coronary thrombi. NETs could, in consequence, be promising targets for improved thrombolysis in AIS. The aim of this study is to assess the impact of NETs composition of thrombi retrieved during endovascular therapy in AIS patients on IV t-PA induced thrombolysis, clinical outcome and AIS etiologies.

NCT ID: NCT02098083 Withdrawn - Acute Stroke Clinical Trials

Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes

PBE
Start date: November 2013
Phase: N/A
Study type: Observational

Data collection for this study will be done by clinicians working in inpatient rehabilitation units with persons with acute stroke. No interventions are included in this study. It is designed to capture trends in current clinical practice for persons with stroke. This data will be useful in identifying the most beneficial and effective walking treatments as well as most significant patient characteristics that impact recovery for persons acutely after stroke. All data collection will take place during the inpatient rehabilitation stay.

NCT ID: NCT01442766 Withdrawn - Acute Stroke Clinical Trials

Donepezil Trial for Motor Recovery in Acute Stroke

Start date: November 2011
Phase: Phase 1/Phase 2
Study type: Interventional

AIMS: To establish: 1) whether motor deficits in acute stroke improve more in patients taking donepezil, relative to placebo, for 12 weeks; 2) whether brain functional MRI changes as a result of donepezil after 12 weeks.

NCT ID: NCT00653536 Withdrawn - Acute Stroke Clinical Trials

A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke

PAO
Start date: March 2008
Phase: Phase 1
Study type: Interventional

Patients with acute ischemic stroke and persistent arterial occlusion following failed mechanical revascularization, who can undergo NeuroFlo treatment within 18 hours of last time symptom free, will be eligible for enrollment to assess the safety and feasibility of the NeuroFlo catheter in treating ischemic stroke patients with persistent arterial occlusion following attempted thrombectomy. The NeuroFlo catheter is designed to partially obstruct the abdominal descending aorta thereby increasing blood flow to the brain. Cerebral perfusion is improved by diverting more blood through vessels as well as by expansion of the collateral circulation. Improved regional perfusion leads to clinical improvement.